NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Institute of Medicine (US) Committee on Implementation of Antiviral Medication Strategies for an Influenza Pandemic. Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program. Washington (DC): National Academies Press (US); 2008.
Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program.
Show detailsCommittee on Implementation of Antiviral Medication Strategies for an Influenza Pandemic
Meeting 2
January 7, 2008
Keck Center of The National Academies
500 Fifth Street, NW
Room 110
Washington, DC 20001
(live audio/video feed provided in Room 105)
| 10:00 am | Influenza Antivirals and Their Use: Effectiveness, Resistance, Surveillance |
| Alexander Klimov Chief, Virus Surveillance and Diagnosis Branch Influenza Division Centers for Disease Control and Prevention | |
| 10:20 am | Mathematical Modeling of Resistance in a Pandemic |
| Marc Lipsitch Professor of Epidemiology Department of Epidemiology Department of Immunology and Infectious Diseases Harvard School of Public Health | |
| 10:40 am | Committee Questions and Discussion |
| 11:00 am | Antiviral Distribution Planning: More from State Public Health Agencies |
| Paul Jarris Executive Director Association of State and Territorial Health Officials | |
| 11:15 am | Committee Questions and Discussion |
| 11:30 am | Lessons from Past Public Health Drug or Vaccine Distribution Campaigns: Swine Flu Immunization Program, Vaccine Shortage, Antibiotic Distribution After Anthrax Attacks |
| Swine Flu | |
| Walter Dowdle Senior Consultant to World Health Organization Polio Eradication Program Task Force on Child Survival and Development | |
| 11:45 am | Lunch |
| 12:45 pm | Lessons from Past Public Health Drug or Vaccine Distribution Campaigns |
| Influenza Vaccine Shortage | |
| Claire Hannan Executive Director Association of Immunization Managers | |
| Anthrax | |
| Eddy Bresnitz Deputy Health Commissioner State Epidemiologist New Jersey | |
| Mary Mahoney Bioterrorism Coordinator North Shore–Long Island Jewish Health System New York | |
| 1:30 pm | Committee Questions and Discussion |
| 1:50 pm | Decision Analysis for Antiviral Distribution |
| Sinan Khan Epidemiology Analyst Los Angeles County Emergency Preparedness and Response Program | |
| Telephone and Web-Based Decision Support and Triage | |
| Barry Wolcott Associate Professor Uniformed Services University of Health Sciences | |
| 2:30 pm | Questions from the Committee and Discussion |
| 2:45 pm | Break |
| 3:00 pm | Antiviral Stockpiling: Stakeholders’ Perspectives |
| Lisa Koonin Associate Director, Business Partnerships Division of Private and Public Partnerships National Center for Health Marketing/CoCHIS Centers for Disease Control and Prevention | |
| Antiviral Distribution Planning: The Public–Private-Sector Interface | |
| Rex Archer Director Kansas City Health Department Missouri | |
| Perspectives from the Private Sector | |
| Katherine B. Andrus Assistant General Counsel Air Transport Association of America, Inc. | |
| Stephen Jones Cluster Occupational Health Manager Downstream and Chemicals ExxonMobil Corporation | |
| Michael McGuire Vice President Roche Laboratories, Inc. | |
| 4:00 pm | Committee Questions and Discussion |
| 4:15 pm | Ethical Principles in Planning for the Distribution of Antiviral Medication |
| Nancy Kass Phoebe R. Berman Professor of Bioethics and Public Health Johns Hopkins University | |
| Ethical Framework in Minnesota’s Plans for Distribution of Antiviral Medication | |
| Dorothy Vawter Associate Director Center for Health Care Ethics Minnesota | |
| 4:45 pm | Committee Questions and Discussion |
| 5:00 pm | Antiviral Distribution Planning (continued) |
| In a Publicly Funded Health Care System | |
| Victoria Davey Deputy Chief, Public Health and Environmental Hazards Officer Veterans Health Administration Department of Veterans Affairs | |
| In a Private Health Care System | |
| Skip Skivington Vice President of Supply Chain and Director of Operations, Procurement and Supply Program Offices Kaiser Permanente | |
| Eric Koscove Chief Emergency Department Kaiser Permanente Medical Center Santa Clara, CA | |
| 5:35 pm | Committee Questions and Discussion |
| 5:50 pm | Public Comment (if time allows) |
| 6:00 pm | Adjourn |
- Meeting Two Agenda - Antivirals for Pandemic InfluenzaMeeting Two Agenda - Antivirals for Pandemic Influenza
- unnamed protein product (mitochondrion) [Gallus gallus]unnamed protein product (mitochondrion) [Gallus gallus]gi|12973|emb|CAA36637.1|Protein
- Plasmodium falciparum mRNA for asparagine-rich antigen (clone 53C6)Plasmodium falciparum mRNA for asparagine-rich antigen (clone 53C6)gi|9856|emb|X17490.1|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...